Home › Non-Small Cell Lung Cancer › Illinois › Cicero
Pag-aaral pangklinika para sa Non-Small Cell Lung Cancer sa Cicero, IL
24 pag-aaral para sa Non-Small Cell Lung Cancer ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Cicero (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
Nagre-recruitPhase 1/2
- Hope And Healing Cancer Services /ID# 276223, Hinsdale · 10 mi ang layo
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Nagre-recruitPhase 3
- Edward Hines Jr VA Hospital, Hines · 4 mi ang layo
- Advocate Christ Medical Center, Oak Lawn · 9 mi ang layo
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Nagre-recruitPhase 3
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi ang layo
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Nagre-recruitPhase 3
- Hope and Healing Cancer Services, Hinsdale · 10 mi ang layo
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Nagre-recruitPhase 3
- Advocate Christ Medical Center, Oak Lawn · 9 mi ang layo
- Hope and Healing Cancer Services, Hinsdale · 10 mi ang layo
- Endeavor Health, Elmhurst · 10 mi ang layo
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
Nagre-recruitPhase 2
- Hope and Healing Clinical Research, Hinsdale · 10 mi ang layo
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Nagre-recruitPhase 3
- Research Site, Hinsdale · 10 mi ang layo
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Nagre-recruitPhase 3
- Affiliated Oncologists, LLC, Chicago Ridge · 10 mi ang layo
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Nagre-recruitPhase 3
- Research Site, Hinsdale · 10 mi ang layo
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Nagre-recruitPhase 2/3
- Loyola University Medical Center, Maywood · 5 mi ang layo
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
Nagre-recruitPhase 3
- Hope and Healing Cancer Services, Hinsdale · 10 mi ang layo
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Nagre-recruitPhase 3
- Affiliated Oncologists, LLC, Chicago Ridge · 10 mi ang layo
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Nagre-recruitPhase 3
- Research Site, Hinsdale · 10 mi ang layo
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Nagre-recruitPhase 3
- Research Site, Hinsdale · 10 mi ang layo
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Nagre-recruitPhase 3
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi ang layo
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Nagre-recruitPhase 3
- Elmhurst Hospital Nancy Knowles Cancer Center, Elmhurst · 10 mi ang layo
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Nagre-recruitPhase 2
- Rush MD Anderson Cancer Center at Rush Oak Park, Oak Park · 3 mi ang layo
- Edward Hines Jr VA Hospital, Hines · 4 mi ang layo
- Loyola University Medical Center, Maywood · 5 mi ang layo
- at 2 pa
MYLUNG Consortium Part 3: Observational Study
Nagre-recruitObservasyonal na pag-aaral
- Affiliated Oncologists, LLC, Chicago Ridge · 10 mi ang layo
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Nagre-recruitPhase 2
- Edward Hines Jr VA Hospital, Hines · 4 mi ang layo
- Loyola University Medical Center, Maywood · 5 mi ang layo
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi ang layo
- at 3 pa
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Nagre-recruitPhase 2/3
- Loyola University Medical Center, Maywood · 5 mi ang layo
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi ang layo
- Advocate Christ Medical Center, Oak Lawn · 9 mi ang layo
- at 2 pa
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Nagre-recruitPhase 2
- Edward Hines Jr VA Hospital, Hines · 4 mi ang layo
- Loyola University Medical Center, Maywood · 5 mi ang layo
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi ang layo
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Nagre-recruitObservasyonal na pag-aaral
- Advocate Christ Medical Center, Oak Lawn · 9 mi ang layo
- Advocate Outpatient Center - Oak Lawn, Oak Lawn · 9 mi ang layo
- Advocate High Tech Medical Park, Palos Heights · 12 mi ang layo
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Nagre-recruit
- Edward Hines Jr. VA Hospital, Hines, IL, Hines · 4 mi ang layo
GEMINI-NSCLC: NSCLC Biomarker Study
Nagre-recruitObservasyonal na pag-aaral
- Hope and Healing Cancer Services, Hinsdale · 10 mi ang layo
Pag-aaral para sa Non-Small Cell Lung Cancer sa ibang lungsod
- Houston, TX145 pag-aaral
- New York City, NY121 pag-aaral
- Arlington, VA104 pag-aaral
- Nashville, TN97 pag-aaral
- Boston, MA90 pag-aaral
- Los Angeles, CA87 pag-aaral
- St. Louis, MO73 pag-aaral
- Chicago, IL61 pag-aaral
- Baltimore, MD60 pag-aaral
- San Antonio, TX59 pag-aaral
- Columbus, OH57 pag-aaral
- Washington, DC55 pag-aaral
Iba pang pag-aaral sa Cicero
- Kanser sa Baga17 pag-aaral
- Kanser sa Prostate14 pag-aaral
- Kanser (lahat ng uri)13 pag-aaral
- Kanser sa Suso11 pag-aaral
- Acute Myeloid Leukemia11 pag-aaral
- Colorectal Cancer10 pag-aaral
- Kanser sa Pantog8 pag-aaral
- Melanoma7 pag-aaral
- Sakit sa Puso at Ugat ng Dugo7 pag-aaral
- Metastatic Cancer7 pag-aaral
- Multiple Myeloma6 pag-aaral
- Burkitt Lymphoma6 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.